EEG University
Meta-analysis and Cost-effectiveness of Second-line Antiepileptic Drugs for Status Epilepticus
Ivan Sanchez Fernandez, Marina Gaınza-Lein, Nathan Lamb, and Tobias Loddenkemper | Accepted 14 May 2019
HEALTH ECONOMICS:
Ceribell leads to improved ROI and significant cost savings as a result of improved patient management
Download ManuscriptBe the First to Know
Subscribe to be notified when new clinical, educational and skill building content is available